Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 5Thoracic 2Gynecologic 2Gastrointestinal 2Plasma cell 1Genitourinary 1

Conditions

Stomach Neoplasms 1Psychological Well-Being 1Motor Activity 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Esophageal Neoplasms 1

Interventions

Carboplatin 351pembrolizumab 323Pemetrexed 248Cisplatin 220Paclitaxel 148Nivolumab 138durvalumab 134osimertinib 112atezolizumab 110Docetaxel 110Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 77Radiosurgery 72Gemcitabine 71Ipilimumab 54130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 45Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Probiotics × Thoracic × 1 year × Clear all
NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Fudan University

Phase 2 Recruiting
60 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

NCT04871412 2026-01-30

POISE

Ottawa Hospital Research Institute

Phase 3 Recruiting
20 enrolled
GastrointestinalThoracic

Psychological Well-Being, Esophageal Neoplasms, Lung Neoplasms, Motor Activity, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡